Abstract
Purpose
To investigate choroidal vascular changes using an image binarization tool in patients with clinically unilateral pseudoexfoliation syndrome (XFS).
Methods
This cross-sectional study included 150 eyes of 100 patients. The eyes were divided into three groups: (1) 50 affected eyes of patients with clinically unilateral XFS; (2) 50 unaffected fellow eyes; and (3) 50 healthy control eyes. Enhanced depth imaging optical coherence tomography scans of the macula and peripapillary regions were acquired. Images were binarized using ImageJ software (National Institutes of Health, Bethesda, MD, USA). The choroidal vascularity index (CVI) was defined as proportion of the luminal area to the total circumscribed choroidal area.
Results
Horizontal and vertical scans revealed that the macular CVI values of the affected eyes (60.08 ± 2.06 and 62.21 ± 2.10, respectively) were lower compared with control eyes (67.31 ± 2.24; p = 0.001 and 68.11 ± 2.36; p < 0.001, respectively). Conversely, no significant difference in the macular CVI was found between unaffected fellow and control eyes (p = 0.094 and p = 0.120, respectively). The mean peripapillary CVI values of the temporal (58.73 ± 3.15), superior (59.84 ± 3.09), and inferior (56.94 ± 2.47) sectors were significantly lower in affected eyes compared to control eyes (63.21 ± 3.00, 62.07 ± 3.05, and 60.78 ± 2.88, respectively; p < 0.05 for all). In addition, the unaffected fellow eyes had significantly lower CVI values in the temporal (61.42 ± 3.07) and inferior (57.61 ± 2.56) peripapillary sectors compared with the control eyes (p = 0.007 and p = 0.005, respectively).
Conclusions
These findings suggest that XFS is associated with decreased macular and peripapillary choroidal vascularity. Furthermore, the unaffected eyes of patients with unilateral XFS may show vascularity changes in the peripapillary choroid.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Plateroti P, Plateroti AM, Abdolrahimzadeh S, Scuderi G. Pseudoexfoliation syndrome and pseudoexfoliation glaucoma: a review of the literature with updates on surgical management. J Ophthalmol. 2015;2015:370371.
Ritch R. Ocular findings in exfoliation syndrome. J Glaucoma 2018;27:S67–71.
Elhawy E, Kamthan G, Dong CQ, Danias J. Pseudoexfoliation syndrome, a systemic disorder with ocular manifestations. Hum Genom. 2012;6:22.
Schlötzer-Schrehardt U, Naumann GO. Ocular and systemic pseudoexfoliation syndrome. Am J Ophthalmol. 2006;141:921–37.
Praveen MR, Shah SK, Vasavada AR, Diwan RP, Shah SM, Zumkhawala BR, et al. Pseudoexfoliation as a risk factor for peripheral vascular disease: a case-control study. Eye. 2011;25:174–9.
Gonen KA, Gonen T, Gumus B. Renal artery stenosis and abdominal aorta aneurysm in patients with pseudoexfoliation syndrome. Eye. 2013;27:735–41.
Demir N, Ulus T, Yucel OE, Kumral ET, Singar E, Tanboga HI. Assessment of myocardial ischaemia using tissue Doppler imaging in pseudoexfoliation syndrome. Eye. 2011;25:1177–80.
Holló G1. Vascular dysfunction in exfoliation syndrome. J Glaucoma. 2018;27:S72–4.
Helbig H, Schlötzer-Schrehardt U, Noske W, Kellner U, Foerster MH, Naumann GO. Anterior-chamber hypoxia and iris vasculopathy in pseudoexfoliation syndrome. Ger J Ophthalmol. 1994;3:148–53.
Parodi MB, Bondel E, Saviano S, Ravalico G. Iris indocyanine green angiography in pseudoexfoliation syndrome and capsular glaucoma. Acta Ophthalmol Scand. 2000;78:437–42.
Schlötzer-Schrehardt U, Küchle M, Naumann GO. Electron-microscopic identification of pseudoexfoliation material in extrabulbar tissue. Arch Ophthalmol. 1991;109:565–70.
Yüksel N, Karabaş VL, Arslan A, Demirci A, Cağlar Y. Ocular hemodynamics in pseudoexfoliation syndrome and pseudoexfoliation glaucoma. Ophthalmology. 2001;108:1043–9.
Dayanir V, Topaloğlu A, Ozsunar Y, Keceli M, Okyay P, Harris A. Orbital blood flow parameters in unilateral pseudoexfoliation syndrome. Int Ophthalmol. 2009;29:27–32.
Cinar E, Yuce B, Aslan F. Retinal and choroidal vascular changes in eyes with pseudoexfoliation syndrome: a comparative study using optical coherence tomography angiography. Balk Med J. 2019;37:9–14.
Agrawal R, Ding J, Sen P, Rousselot A, Chan A, Nivison-Smith L, et al. Exploring choroidal angioarchitecture in health and disease using choroidal vascularity index. Prog Retin Eye Res. 2020; https://doi.org/10.1016/j.preteyeres.2020.100829.
Turan-Vural E, Yenerel N, Okutucu M, Yildiz E, Dikmen N. Measurement of subfoveal choroidal thickness in pseudoexfoliation syndrome using enhanced depth imaging optical coherence tomography. Ophthalmologica. 2015;233:204–8.
Goktas S, Sakarya Y, Ozcimen M, Sakarya R, Bukus A, Ivacik IS, et al. Choroidal thinning in pseudoexfoliation syndrome detected by enhanced depth imaging optical coherence tomography. Eur J Ophthalmol. 2014;24:879–84.
Sarrafpour S, Adhi M, Zhang JY, Duker JS, Krishnan C. Choroidal vessel diameters in pseudoexfoliation and pseudoexfoliation glaucoma analyzed using spectral-domain optical coherence tomography. J Glaucoma. 2017;26:383–9.
Zengin MO, Cinar E, Karahan E, Tuncer I, Yilmaz S, Kocaturk T, et al. Choroidal thickness changes in patients with pseudoexfoliation syndrome. Int Ophthalmol. 2015;35:513–7.
Ozge G, Koylu MT, Mumcuoglu T, Gundogan FC, Ozgonul C, Ayyildiz O, et al. Evaluation of retinal nerve fiber layer thickness and choroidal thickness in pseudoexfoliative glaucoma and pseudoexfoliative syndrome. Postgrad Med. 2016;128:444–8.
You QS, Xu L, Wang YX, Yang H, Ma K, Li JJ, et al. Pseudoexfoliation: normative data and associations: the Beijing eye study 2011. Ophthalmology. 2013;120:1551–8.
Agrawal R, Salman M, Tan KA, Karampelas M, Sim DA, Keane PA, et al. Choroidal vascularity index (CVI)–a novel optical coherence tomography parameter for monitoring patients with panuveitis? PLoS One. 2016;11:e0146344.
Nickla DL, Wallman J. The multifunctional choroid. Prog Retin Eye Res. 2010;29:144–68.
Kim RY, Chung DH, Kim M, Park YH. Use of choroidal vascularity index for choroidal structural evaluation in central serous chorioretinopathy with choroidal neovascularization. Retina. 2019; https://doi.org/10.1097/IAE.0000000000002585.
Wei X, Mishra C, Kannan NB, Holder GE, Khandelwal N, Kim R, et al. Choroidal structural analysis and vascularity index in retinal dystrophies. Acta Ophthalmol. 2019;97:e116–21.
Pellegrini M, Giannaccare G, Bernabei F, Moscardelli F, Schiavi C, Campos EC. Choroidal vascular changes in arteritic and nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol. 2019;205:43–9.
Cetin EN, Parca O, Akkaya HS, Pekel G. Association of retinal biomarkers and choroidal vascularity index on optical coherence tomography using binarization method in retinitis pigmentosa. Graefes Arch Clin Exp Ophthalmol. 2020;258:23–30.
Wang W, Zhou M, Huang W, Chen S, Ding X, Zhang X. Does acute primary angle-closure cause an increased choroidal thickness? Investig Ophthalmol Vis Sci. 2013;54:3538–45.
Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med. 2016;15:155–63.
Atalar PT, Atalar E, Kilic H, Abbasoglu OE, Ozer N, Aksöyek S, et al. Impaired systemic endothelial function in patients with pseudoexfoliation syndrome. Int Heart J. 2006;47:77–84.
Wang W, He M, Zhou M, Zhang X. Ocular pseudoexfoliation syndrome and vascular disease: a systematic review and meta-analysis. PLoS One. 2014;9:e92767.
Chung H, Arora S, Damji KF, Weis E. Association of pseudoexfoliation syndrome with cardiovascular and cerebrovascular disease: a systematic review and meta-analysis. Can J Ophthalmol. 2018;53:365–72.
Grødum K, Heijl A, Bengtsson B. Risk of glaucoma in ocular hypertension with and without pseudoexfoliation. Ophthalmology. 2005;112:386–90.
Leske MC, Heijl A, Hyman L, Bengtsson B, Dong L, Yang Z, et al. Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology. 2007;114:1965–72.
Ozaki M. Mechanisms of glaucoma in exfoliation syndrome. J Glaucoma. 2018;27:S83–6.
Grieshaber MC, Mozaffarieh M, Flammer J. What is the link between vascular dysregulation and glaucoma? Surv Ophthalmol. 2007;52:S144–54.
Flammer J, Orgül S, Costa VP, Orzalesi N, Krieglstein GK, Serra LM, et al. The impact of ocular blood flow in glaucoma. Prog Retin Eye Res. 2002;21:359–93.
Agrawal R, Gupta P, Tan KA, Cheung CM, Wong TY, Cheng CY. Choroidal vascularity index as a measure of vascular status of the choroid: Measurements in healthy eyes from a population-based study. Sci Rep. 2016;6:21090.
Eroglu FC, Asena L, Simsek C, Kal A, Yılmaz G. Evaluation of choroidal thickness using enhanced depth imaging by spectral-domain optical coherence tomography in patients with pseudoexfoliation syndrome. Eye. 2015;29:791–6.
Dursun A, Ozec AV, Dogan O, Dursun FG, Toker MI, Topalkara A, et al. Evaluation of choroidal thickness in patients with pseudoexfoliation syndrome and pseudoexfoliation glaucoma. J Ophthalmol. 2016;2016:3545180.
Yang L, Jonas JB, Wei W. Choroidal vessel diameter in central serous chorioretinopathy. Acta Ophthalmol. 2013;91:e358–e362.
Park KA, Oh SY. An optical coherence tomography-based analysis of choroidal morphologic features and choroidal vascular diameter in children and adults. Am J Ophthalmol. 2014;158:716–23.e2.
Funding
The authors indicate they have no financial disclosures. The authors, their families, their employers and their business associates have no financial or proprietary interest in any product or company associated with any device, instrument or drug mentioned in this article. The authors have not received any payment as consultants, reviewers or evaluators of any of the devices, instruments or drugs mentioned in this article.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the Ankara Education and Research Hospital (Report Number: 2019-113) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Disclosure statement: The authors report no conflicts of interest and have no proprietary interest in any of the materials mentioned in this article. This article has been read and approved by all the authors. This research received no specific grant and/or equipment from any funding agency in the public, commercial, or not-for-profit sectors.
Rights and permissions
About this article
Cite this article
Simsek, M., Inam, O., Sen, E. et al. Peripapillary and macular choroidal vascularity index in patients with clinically unilateral pseudoexfoliation syndrome. Eye 35, 1712–1720 (2021). https://doi.org/10.1038/s41433-020-01171-9
Received:
Revised:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41433-020-01171-9
This article is cited by
-
Macular and peripapillary Choroidal Vascularity Index in children with different refractive status
Eye (2024)
-
Choroidal vascularity index in pseudoexfoliation syndrome: a review of the literature
Spektrum der Augenheilkunde (2023)
-
Changes in the peripapillary and subfoveal choroidal vascularity index after transsphenoidal surgery for pituitary macroadenoma
International Ophthalmology (2022)
-
Choroidal vascularity index in pseudoexfoliative glaucoma
International Ophthalmology (2021)
